ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,856,593 | -33.3% | 2,360,129 | -6.3% | 1.20% | -15.5% |
| Q2 2023 | $16,279,200 | -14.3% | 2,520,000 | 0.0% | 1.42% | -9.1% |
| Q1 2023 | $19,000,800 | -17.4% | 2,520,000 | +11.0% | 1.56% | -12.2% |
| Q4 2022 | $22,995,100 | +40.9% | 2,270,000 | +37.6% | 1.78% | +66.2% |
| Q3 2022 | $16,319,000 | +104.3% | 1,650,000 | +120.0% | 1.07% | +58.8% |
| Q2 2022 | $7,988,000 | -0.7% | 750,000 | +275.0% | 0.68% | +183.6% |
| Q4 2020 | $8,048,000 | – | 200,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |